Espoo, Finland

Eeva-Marjatta Salonen


Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1989-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Eeva-Marjatta Salonen: Innovator in Urokinase-type Plasminogen Activator Research

Introduction: Eeva-Marjatta Salonen is a prominent inventor based in Espoo, Finland, known for her significant contributions to the field of medical research. With a total of five patents to her name, Salonen’s work primarily focuses on the urokinase-type plasminogen activator (uPA) and its receptor, which plays a crucial role in various physiological processes.

Latest Patents: Salonen's latest patents demonstrate her innovative approach to her research. One notable patent involves the inhibition of the activation of plasminogen to plasmin by preventing the binding of the receptor binding form of urokinase-type plasminogen activator to its receptor in mammals. This mechanism effectively stops the conversion of plasminogen into plasmin. Additionally, her patents provide DNA fragments that encode for soluble, active fragments of the urokinase-type plasminogen activator receptor and outline vectors and methods for the recombinant production of these uPA-binding fragments.

Career Highlights: Salonen has had a productive career, including significant roles at Labsystems Oy and Cancerforskningsfondet. Her inventions not only contribute to biomedical research but also have potential implications for cancer treatment and management.

Collaborations: Throughout her career, Salonen has collaborated with esteemed colleagues, including Francesco Blasi and Ann Louring Roldan. These partnerships illustrate the collaborative nature of scientific innovation and the importance of teamwork in advancing research.

Conclusion: Eeva-Marjatta Salonen’s work exemplifies the impact of innovative thinking in the medical field. Through her patents and collaborations, she continues to contribute valuable insights into the mechanisms and applications of urokinase-type plasminogen activator research, setting a foundation for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…